AK
Arthur Asher Kornbluth
Director
Arthur Asher KornbluthDirector
Arthur Asher Kornbluth insider trades: CB Pharma Acquisition (CNLM) SEC Form 4 filings
Director, CB Pharma Acquisition 1 Form 4 filing
1
Form 4 filings
last May 23, 2016
1
Company
Companies
Where Arthur reports to the SEC
About Arthur Asher Kornbluth's insider trades
Arthur Asher Kornbluth is a director at CB Pharma Acquisition (CNLM). Arthur has not reported an open-market purchase or sale.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every CNLM insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.